{
    "sid": 2589393,
    "pkdb_version": 1.0,
    "creator": "mkoenig",
    "name": "Harder1989",
    "design": "",
    "reference": 2589393,
    "curators": [
        "mkoenig",
        "janekg"
    ],
    "substances": [
        "caffeine"
    ],
    "groupset": {
        "description": "In two consecutive studies, each in 12 healthy male volunteers (age 20-40 years), the pharmacokinetics of caffeine and its major metabolite paraxanthine alone and at the end of 4 days of treatment with several quinolones (Table 1) were investigated. Thine- free diet (no tea, coffee or chocolate) from 36 h before the first dose of caffeine until the end of the second sampling period.",
        "groups": [
            {
                "count": 12,
                "name": "S1",
                "characteristica": [
                    {
                        "category": "ethnicity",
                        "choice": null
                    },
                    {
                        "category": "healthy",
                        "choice": "Y"
                    },
                    {
                        "category": "sex",
                        "choice": "M"
                    },
                    {
                        "category": "species",
                        "choice": "homo sapiens"
                    },
                    {
                        "category": "age",
                        "min": "20",
                        "max": "40",
                        "unit": "yr"
                    },
                    {
                        "category": "oral contraceptives",
                        "choice": null
                    }
                ]
            }
        ]
    },
    "interventionset": {
        "description": "Caffeine and paraxanthine concentrations in plasma were simultaneously determined after a single oral dose of 230 mg caffeine in a liquid preparation. Blood samples were collected 0.5, 1, 2, 4, 6, 10, 14, 20 and 24 h after the administration of caffeine.||Quinolones were given after completion of the caffeine-alone phase. All subjects received quinolones b.d. for 3 days. On the fourth day a last single dose of the quinolone was. given together with a second dose of caffeine, followed by a further 24-h blood sampling period.",
        "interventions": [
            {
                "name": "D_CAF",
                "substance": "caffeine",
                "time": "0",
                "time_unit": "h",
                "route": "oral",
                "value": 230.0,
                "unit": "mg"
            },
            {
                "name": "D_OFL",
                "substance": "ofloxacin",
                "time": "0||24||48||72",
                "time_unit": "h",
                "route": "oral",
                "value": 200.0,
                "unit": "mg"
            },
            {
                "name": "D_NOR",
                "substance": "norfloxacin",
                "time": "0||24||48||72",
                "time_unit": "h",
                "route": "oral",
                "value": 400.0,
                "unit": "mg"
            },
            {
                "name": "D_PPA",
                "substance": "pipemidic acid",
                "time": "0||24||48||72",
                "time_unit": "h",
                "route": "oral",
                "value": 400.0,
                "unit": "mg"
            },
            {
                "name": "D_CIP1",
                "substance": "ciprofloxacin",
                "time": "0||24||48||72",
                "time_unit": "h",
                "route": "oral",
                "value": 100.0,
                "unit": "mg"
            },
            {
                "name": "D_CIP2",
                "substance": "ciprofloxacin",
                "time": "0||24||48||72",
                "time_unit": "h",
                "route": "oral",
                "value": 250.0,
                "unit": "mg"
            },
            {
                "name": "D_CIP3",
                "substance": "ciprofloxacin",
                "time": "0||24||48||72",
                "time_unit": "h",
                "route": "oral",
                "value": 500.0,
                "unit": "mg"
            },
            {
                "name": "D_ENX1",
                "substance": "enoxacin",
                "time": "0||24||48||72",
                "time_unit": "h",
                "route": "oral",
                "value": 100.0,
                "unit": "mg"
            },
            {
                "name": "D_ENX2",
                "substance": "enoxacin",
                "time": "0||24||48||72",
                "time_unit": "h",
                "route": "oral",
                "value": 200.0,
                "unit": "mg"
            },
            {
                "name": "D_ENX3",
                "substance": "enoxacin",
                "time": "0||24||48||72",
                "time_unit": "h",
                "route": "oral",
                "value": 400.0,
                "unit": "mg"
            }
        ]
    },
    "outputset": {
        "description": "",
        "outputs": [
            {
                "group": "S1",
                "intervention": "D_CAF",
                "substance": "caffeine",
                "pktype": "clearance",
                "value": 164.0,
                "tissue": "plasma",
                "sd": 70.0,
                "unit": "ml/h/kg"
            },
            {
                "group": "S1",
                "intervention": "D_CAF; D_OFL",
                "substance": "caffeine",
                "pktype": "clearance",
                "value": 160.0,
                "tissue": "plasma",
                "sd": 67.0,
                "unit": "ml/h/kg"
            }
        ]
    }
}